Vitruvias Therapeutics, Inc.

Vitruvias Therapeutics, Inc. lists 14 drug products in the FDA National Drug Code directory.

Products

NDCProductStrengthType
69680-186Icosapent Ethyl
Capsule
Icosapent Ethyl 1 g/1Rx
69680-161Memantine Hydrochloride
Capsule, Extended Release
Memantine Hydrochloride 7 mg/1Rx
69680-162Memantine Hydrochloride
Capsule, Extended Release
Memantine Hydrochloride 14 mg/1Rx
69680-163Memantine Hydrochloride
Capsule, Extended Release
Memantine Hydrochloride 21 mg/1Rx
69680-164Memantine Hydrochloride
Capsule, Extended Release
Memantine Hydrochloride 28 mg/1Rx
69680-183memantine hydrochloride and donepezil hydrochloride
Capsule, Extended Release
Memantine Hydrochloride 14 mg/1; Donepezil Hydrochloride 10 mg/1Rx
69680-185memantine hydrochloride and donepezil hydrochloride
Capsule, Extended Release
Memantine Hydrochloride 28 mg/1; Donepezil Hydrochloride 10 mg/1Rx
69680-146Pramipexole Dihydrochloride
Tablet, Extended Release
Pramipexole Dihydrochloride .75 mg/1Rx
69680-145Pramipexole Dihydrochloride Extended-Release
Tablet, Extended Release
Pramipexole Dihydrochloride .375 mg/1Rx
69680-177Topiramate
Capsule, Extended Release
Topiramate 25 mg/1Rx
69680-178Topiramate
Capsule, Extended Release
Topiramate 50 mg/1Rx
69680-179Topiramate
Capsule, Extended Release
Topiramate 100 mg/1Rx
69680-180Topiramate
Capsule, Extended Release
Topiramate 150 mg/1Rx
69680-181Topiramate
Capsule, Extended Release
Topiramate 200 mg/1Rx